Others conceptualized that the presence of antibodies against calreticulin, heat shock protein 70, tumor necrosis factor alpha, interleukin-18, or NY-ESO-1 or other cytokines after RT can identify patients who are susceptible to ARs.45 This evidence concerns the gene IL18 and Axenfeld-Rieger syndrome.